VivoSim Labs, Inc. Form 10-KT: Transition report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-05-24: Form 10-KT; Period of report 2013-03-31; Description FORM 10-KT; Document d519346d10kt.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2013-05-24 | 10-KT | 2013-03-31 | FORM 10-KT | d519346d10kt.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |